Macrophage-targeted and clearable glutathione-based MRI nanoprobes for atherosclerosis molecular imaging
- 10 Downloads
Foam macrophage infiltration is one of the clinical features of high-risk atherosclerotic plaques. Many imaging modalities such as magnetic resonance imaging (MRI) have been used to detect foam macrophages for evaluating plaque vulnerability. However, targeting efficiency, biocompatibility, and clearance remain pivotal challenges in design of new MRI contrast agents. Herein, we report a sensitive, class AI scavenger receptors (SR-AI)-targeted, glutathione-biomineralized gadolinium-based nanoparticle for noninvasive precise MR imaging of macrophages within carotid atherosclerotic lesions in apoE-deficient (ApoE−/−) mice. The resultant PP1 (16-mer peptide, LSLERFLRCWSDAPAK)-gold-gadolinium nanoparticles (NPs) possessed superior stability, prominent longitudinal relaxivity, and negligible cytotoxicity. In vitro results showed the highest internalization in activated macrophages and in vivo MR images revealed signal augment in carotid atherosclerotic lesions after PP1-gold-gadolinium NP administration at 4 h and 12 h, which were strong testimonial to the formidable macrophage-targeting ability and the subsequent atherosclerosis-retention biofunctions. To summarize, our tactically elaborated biocompatible multifunctional MR NPs integrate T1 signal amplification, precise macrophage targeting, and systematic clearance capabilities, which offer an innovative strategy for noninvasively characterizing vulnerable plaques of early-stage atherosclerosis, or for a wide range of clinical diagnosis and treatment applications.
KeywordsClearable nanoparticles Macrophage targeting MRI Atherosclerosis Nanomedicine
This study was funded by the National Natural Science Foundation of China (81701826), Key Project of Tianjin Natural Science Foundation (16KPXMSF00140), Key Project of Tianjin Health and Family Planning Commission (16KG115), and Science Foundation of the Second Hospital of Tianjin Medical University (2017YDEY11, 2018YDEY11).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- Deng S, Zhang W, Zhang B, Hong R, Chen Q, Dong J, Chen Y, Chen Z, Wu Y (2015) Radiolabeled cyclic arginine-glycine-aspartic (RGD)-conjugated iron oxide nanoparticles as single-photon emission computed tomography (SPECT) and magnetic resonance imaging (MRI) dual-modality agents for imaging of breast cancer. J Nanopart Res 17:19CrossRefGoogle Scholar
- Hiltunen TP, Luoma JS, Nikkari T, Ylä-Herttuala S (1998) Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and Scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation 97:1079–1086CrossRefGoogle Scholar
- Segers FM, den Adel B, Bot I, van Graaf LM, Veer EP, Gonzalez W, Raynal I, de Winther M, Wodzig WK, Poelmann RE, van Berkel TJ, van Weerd L, Biessen EA (2013) Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions. Arterioscler Thromb Vasc Biol 33:1812–1819CrossRefGoogle Scholar
- Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, Takashima Y, Kawabe Y, Cynshi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y, Horiushi S, Takahashi K, Kruijt JK, Berkel TJ, Steinbrecher UP, Ishibashi S, Maeda N, Gordon S, Kodama T (1997) A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386:292–296CrossRefGoogle Scholar
- Zhao Y, Peng J, Li J, Huang L, Yang J, Huang K, Li H, Jiang N, Zheng S, Zhang X, Niu Y, Han G (2017) Tumor-targeted and clearable human protein-based MRI nanoprobes. Nano Lett 8:28Google Scholar